State Street’s NeuroOne Medical Technologies NMTC Stock Holding History

State Street’s Portfolio NMTC Stock Details NMTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$46.2K	Hold	9,917	–	–	﹤0.01%	4141
2025 Q4	$45.1K	Hold	9,917	–	–	﹤0.01%	4170
2025 Q3	$52.9K	Hold	9,917	–	–	﹤0.01%	4149
2025 Q2	$40.4K	Hold	9,917	–	–	﹤0.01%	4123
2025 Q1	$50.6K	Hold	9,917	–	–	﹤0.01%	4095
2024 Q4	$49.1K	Hold	9,917	–	–	﹤0.01%	4110
2024 Q3	$58.9K	Hold	9,917	–	–	﹤0.01%	4072
2024 Q2	$47.6K	Buy	9,917 +1,317	+15%	+$8.28K	﹤0.01%	4149
2024 Q1	$61.9K	Hold	8,600	–	–	﹤0.01%	4123
2023 Q4	$81.5K	Hold	8,600	–	–	﹤0.01%	4094
2023 Q3	$45.9K	Buy	8,600 +2,617	+44%	+$17.5K	﹤0.01%	4304
2023 Q2	$43.1K	Hold	5,983	–	–	﹤0.01%	4457
2023 Q1	$57.8K	Hold	5,983	–	–	﹤0.01%	4469
2022 Q4	$43.1K	Hold	5,983	–	–	﹤0.01%	4589
2022 Q3	$61K	Buy	+5,983	New	+$56.9K	﹤0.01%	4613

Other funds holding NMTC

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

State Street's NMTC Position: Q1 2026 in Review

State Street held its NeuroOne Medical Technologies (NMTC) position steady in Q1 2026 at 9,917 shares worth $46.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4141.

State Street first reported a position in NMTC in Q3 2022 and has held it in 15 quarters since. The position peaked at $81.5K in Q4 2023. 32 funds tracked by Wall St. Rank hold NMTC as of Q1 2026.

State Street held 9,917 shares of NeuroOne Medical Technologies worth $46.2K as of Q1 2026.
State Street left its NeuroOne Medical Technologies share count unchanged in Q1 2026.
NeuroOne Medical Technologies made up ﹤0.01% of State Street's portfolio in Q1 2026, its #4141 holding.
State Street first reported a position in NeuroOne Medical Technologies in Q3 2022 and has held it in 15 quarters since.
State Street's NeuroOne Medical Technologies position peaked at $81.5K in Q4 2023.
32 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.